InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: Supernova12 post# 19801

Tuesday, 02/28/2012 11:45:29 AM

Tuesday, February 28, 2012 11:45:29 AM

Post# of 330174
Hi Super - Think your reference to throwing in world peace making the list of approvals a little on the side of dismissive of the previous poster. What I mean is that the product approval list seemed to follow well on the heels of the question as to if the FDA is considering a multi-product approval concept.
I am not suggesting they may or may not be, but I liked both the question and the approval list.
As a user of ActiPatch for a very badly sprained ankle, I know it worked almost miraculously. Days to walking pain free versus my doc suggesting a few weeks and lending me some crutches which I returned in 2 or 3 days. I left it on and it obliterated the pain.
Secondly, I know the FDA has already approved BIEL's PEMF device for post-op eye surgery treatment - around the eye and close to the brain, making the noise about comparing PEMF to cell phones and other devices absurd - so PEMF and specifically BIEL's device are already approved. Nice.....
The other indications applied for are potentially incredible if approved. Sales of ActiPatch and ALLAY are potentially huge in the USA - can you imaging how many women suffer from pains and cramps from monthly cycles and pop pills for a week or so every month for it, thus treating the other spousal and familial issues for them and all around them? Can you imagine - no more chemical painkillers, every month of every year?
I see no reason whatsover why BIEL will not receive approval. PEMF is already out of the box. I cannot imagine a doctor prescribing the BIEL device for an eye surgey patient going through a process of questioning his patient, "do you currently, or have you ever had a sensitivity to PEMF?" Nonsense - PEMF and BIEL are approved for prescription by doctors for post-op eye surgery patients. I bought it from a friend in Canada, I used ActiPatch, I could not believe how well it worked. Next?